UK Research and Innovation (UKRI) announced on October 2, 2026 that it is backing a programme called the Dementia Challenge with up to £80 million, funding nine separate projects that will be tested inside the National Health Service over the coming months. The money comes through UKRI's Research and Development Missions Accelerator Programme, and the stated goal is to raise the share of people diagnosed with dementia within 18 weeks of referral to 92%, up from roughly 60% today, when the process can currently take more than a year in some areas.

The nine projects include a University College London and UK Dementia Research Institute effort to cut diagnostic MRI scan times from around 20 minutes to about 7 minutes; a University of Exeter digital platform intended to help people monitor cognitive changes and be assessed at the right time; a home sensor and artificial intelligence system called Minder, developed by the UK Dementia Research Institute Care Research and Technology Centre at Imperial College London; a panel of blood based biomarkers from the University of Oxford and Dementias Platform UK, validated through the Blood Biomarker Challenge funded READ OUT study, intended for routine NHS memory services; and a 15 minute remote digital cognitive assessment from Cognitron. Other funded work includes an AI enabled clinical decision support tool at the University of Cambridge that analyses routinely collected medical records, blood tests and cognitive test results to help predict how the disease will progress, and a project to redesign dementia diagnosis and treatment services in Scotland.

UKRI has built in what it calls a fail fast structure: projects receive initial funding to run in real NHS settings, and only those that demonstrate a measurable benefit during that testing will be awarded further money to scale up. That means none of the nine technologies has yet been shown, in a completed trial, to actually deliver the 18 week target or to improve diagnostic accuracy in practice. Science minister Chris McDonald and UKRI Health Mission Challenge director Andy Hill both framed the funding as a step toward earlier access to treatment and support for people living with dementia and their families, while Alzheimer Scotland's chief executive welcomed the investment, in particular the Scottish service redesign project.